Author: Liu, Margaret A.
Title: A Comparison of Plasmid DNA and mRNA as Vaccine Technologies Document date: 2019_4_24
ID: 0fx1b7ph_12
Snippet: As noted above, the ability to make either a plasmid DNA or an mRNA construct quickly by simply knowing the genetic sequence of a desired antigen makes plasmid DNA or mRNA much faster technologies (compared to current approaches) to produce a vaccine, if needed, for an epidemic or an emerging disease. Five characteristics-rapidity of making constructs, relatively temporary presence in vivo of the encoded protein, amplification by the immune syste.....
Document: As noted above, the ability to make either a plasmid DNA or an mRNA construct quickly by simply knowing the genetic sequence of a desired antigen makes plasmid DNA or mRNA much faster technologies (compared to current approaches) to produce a vaccine, if needed, for an epidemic or an emerging disease. Five characteristics-rapidity of making constructs, relatively temporary presence in vivo of the encoded protein, amplification by the immune system responding to even small amounts of expressed protein, the manufacturing advantages (generic and rapid processes compared to drugs or recombinant proteins), and the intrinsic immunostimulatory properties of both plasmid DNA and mRNA-combine to make a compelling rationale for vaccines to be viewed as the best initial targets for widespread development efforts for both technologies.
Search related documents:
Co phrase search for related documents- current approach and genetic sequence: 1
- current approach and immune system: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- current approach and initial target: 1
- current approach and plasmid dna: 1
- current approach and recombinant protein: 1
- current approach and small amount: 1, 2
Co phrase search for related documents, hyperlinks ordered by date